EDGAR Filing Documents for 0001213900-20-038924

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001213900-20-038924

Filing Date

2020-11-24

Accepted

2020-11-24 07:37:19

Documents

Period of Report

2020-08-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f10k2020_oramedpharma.htm	10-K	1182681
2	COMPOSITE COPY OF CERTIFICATE OF INCORPORATION, AS AMENDED AS OF JANUARY 22, 201	f10k2020ex3-1_oramedpharma.htm	EX-3.1	14285
3	COMPOSITE COPY OF CERTIFICATE OF INCORPORATION, AS AMENDED AS OF JANUARY 22, 201	f10k2020ex3-2_oramedpharma.htm	EX-3.2	10278
4	DESCRIPTION OF SECURITIES	f10k2020ex4-4_oramedpharma.htm	EX-4.4	10384
5	CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	f10k2020ex23-1_oramedpharma.htm	EX-23.1	3543
6	CERTIFICATION	f10k2020ex31-1_oramedpharma.htm	EX-31.1	7878
7	CERTIFICATION	f10k2020ex31-2_oramedpharma.htm	EX-31.2	8134
8	CERTIFICATION	f10k2020ex32-1_oramedpharma.htm	EX-32.1	3600
9	CERTIFICATION	f10k2020ex32-2_oramedpharma.htm	EX-32.2	3577
10	GRAPHIC	img_001.jpg	GRAPHIC	35679
11	GRAPHIC	img_002.jpg	GRAPHIC	5314
12	GRAPHIC	image_001.jpg	GRAPHIC	2314
	Complete submission text file	0001213900-20-038924.txt		5061209

Data Files

Seq	Description	Document	Type	Size
13	XBRL INSTANCE FILE	ormp-20200831.xml	EX-101.INS	696434
14	XBRL SCHEMA FILE	ormp-20200831.xsd	EX-101.SCH	64053
15	XBRL CALCULATION FILE	ormp-20200831_cal.xml	EX-101.CAL	32790
16	XBRL DEFINITION FILE	ormp-20200831_def.xml	EX-101.DEF	275616
17	XBRL LABEL FILE	ormp-20200831_lab.xml	EX-101.LAB	542618
18	XBRL PRESENTATION FILE	ormp-20200831_pre.xml	EX-101.PRE	293015

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164

ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)